Clinical Trial

Minimal Effective Volume 90% for Double-injection Costoclavicular Block

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In 2020, a trial demonstrated that a 2-injection technique constitutes the optimal method for the costoclavicular block. This study aims to determine the minimum amount of medication required to achieve a successful double-injection costoclavicular nerve. Block dose assignment will be done using an up-and-down sequential method, called the Biased Coin Design (BCD). The double-injection technique for US-guided costoclavicular block consists in depositing two thirds of the LA volume in the deep compartment (to anesthetize the posterior and medial cords), and one third of the injectate in the superficial compartment (to anesthetize the lateral cord). The ED90 will be calculated using isotonic regression with a 95% confidence interval derived by bootstrapping.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-08
Trial Details
NCT Number NCT07374952
Lead Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions Brachial Plexus Blocks, Lidocaine, Nerve Block, Dose Finding Study, Costoclavicular Block
Enrollment 60 participants
Start Date 2026-06-16
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07